Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$0 Mln
P/E Ratio
--
P/B Ratio
11.23
Industry P/E
--
Debt to Equity
0
ROE
-15.08 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-125.80 Mln
EBITDA
$-130.91 Mln
Net Profit
$-141.61 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
| -96.25 | 1,400.00 | -96.25 | -94.63 | -84.54 | -71.12 | -67.32 |
|
BSE Sensex*
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
| 66.67 | -85.62 | -66.06 | -14.88 | -15.74 | -79.34 | -52.91 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 20.01 | 50.77 | -- | -61.67 |
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty... acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Address: 19 Presidential Way, Woburn, MA, United States, 01801 Read more
Co-Founder, President, CEO & Director
Dr. Oliver P. Peoples Ph.D.
Co-Founder, President, CEO & Director
Dr. Oliver P. Peoples Ph.D.
Headquarters
Woburn, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Yield10 Bioscience Inc (YTEN) stood at $ 11 Mln as on 30-Jun-24
The share price of Yield10 Bioscience Inc (YTEN) is $0.02 (NASDAQ) as of 21-Feb-2025 09:30 EDT. Yield10 Bioscience Inc (YTEN) has given a return of -84.54% in the last 3 years.
Yield10 Bioscience Inc (YTEN) has a market capitalisation of $ 0 Mln as on 21-Feb-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Yield10 Bioscience Inc (YTEN) is 11.23 times as on 21-Feb-2025, a 408% premium to its peers’ median range of 2.21 times.
Since, TTM earnings of Yield10 Bioscience Inc (YTEN) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Yield10 Bioscience Inc (YTEN) and enter the required number of quantities and click on buy to purchase the shares of Yield10 Bioscience Inc (YTEN).
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Address: 19 Presidential Way, Woburn, MA, United States, 01801
The CEO & director of Dr. Oliver P. Peoples Ph.D.. is Yield10 Bioscience Inc (YTEN), and CFO & Sr. VP is Dr. Oliver P. Peoples Ph.D..
There is no promoter pledging in Yield10 Bioscience Inc (YTEN).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
5
|
| Yield10 Bioscience Inc. (YTEN) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-1153.83
|
|
Net Margin(%)
|
-1568.15
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Yield10 Bioscience Inc (YTEN) was $0 Mln.
